ArticleScientific reports2021

Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice.

Di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.